We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+2.46%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$4.93B
AUM Growth
+$1.15B
Cap. Flow
+$1.17B
Cap. Flow %
23.66%
Top 10 Hldgs %
15.43%
Holding
758
New
275
Increased
122
Reduced
113
Closed
194

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$106M
2
AGN
Allergan plc
AGN
+$93.1M
3
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$79.9M
4
BPL
Buckeye Partners, L.P.
BPL
+$75.8M
5
NNN icon
NNN REIT
NNN
+$47.1M

Top Sells

Rank Stock Value
1
CUZ icon
Cousins Properties
CUZ
+$87.3M
2
VICI icon
VICI Properties
VICI
+$58.6M
3
VTR icon
Ventas
VTR
+$50.3M
4
BXP icon
Boston Properties
BXP
+$39.8M
5
COLD icon
Americold
COLD
+$34.5M

Sector Composition

Rank Sector Weight
1 Real Estate 18.43%
2 Technology 10.03%
3 Industrials 7.7%
4 Healthcare 6.67%
5 Energy 5.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGMO
526
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$272K 0.01%
30,000
– –
PEN icon
527
Penumbra
PEN
$12.6B
$269K 0.01%
+2,000
New +$309K
BLU
528
DELISTED
BELLUS Health Inc.
BLU
$256K 0.01%
+40,000
New +$282K
CLVS
529
DELISTED
Clovis Oncology, Inc.
CLVS
$255K 0.01%
65,000
+5,000
+8% +$40.4K
PGNX
530
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$253K 0.01%
50,000
– –
BN icon
531
Brookfield
BN
$103B
$251K 0.01%
+13,226
New +$239K
MDCO
532
CALL
DELISTED
Medicines Co
MDCO
$250K 0.01%
+5,000
New +$199K
VRAY
533
DELISTED
ViewRay, Inc.
VRAY
$247K 0.01%
85,000
+35,000
+70% +$207K
OPRT icon
534
Oportun Financial
OPRT
$263M
$243K ﹤0.01%
+15,000
New +$243K
GBT
535
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
$243K ﹤0.01%
+5,000
New +$261K
AXTA icon
536
CALL
Axalta
AXTA
$7.26B
$241K ﹤0.01%
+8,000
New +$236K
KPTI icon
537
Karyopharm Therapeutics
KPTI
$172M
$241K ﹤0.01%
1,667
– –
RETA
538
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$241K ﹤0.01%
+3,000
New +$255K
RCKT icon
539
Rocket Pharmaceuticals
RCKT
$355M
$233K ﹤0.01%
20,000
+3,000
+18% +$37.2K
ITCI
540
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$224K ﹤0.01%
30,000
– –
BRKR icon
541
Bruker
BRKR
$9.23B
$220K ﹤0.01%
+5,000
New +$224K
XLRN
542
DELISTED
Acceleron Pharma
XLRN
$217K ﹤0.01%
5,500
+500
+10% +$21.7K
BHVN
543
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$209K ﹤0.01%
5,000
– –
BHVN
544
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$209K ﹤0.01%
+5,000
New +$211K
STML
545
DELISTED
Stemline Therapeutics, Inc.
STML
$208K ﹤0.01%
+20,000
New +$262K
OBSV
546
DELISTED
ObsEva SA Ordinary Shares
OBSV
$200K ﹤0.01%
24,000
+1,000
+4% +$9.54K
GLNG icon
547
Golar LNG
GLNG
$4.88B
$195K ﹤0.01%
15,000
-6,000
-29% -$88.2K
PRTK
548
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$190K ﹤0.01%
44,000
– –
HRTX icon
549
Heron Therapeutics
HRTX
$88.1M
$185K ﹤0.01%
10,000
– –
VYGR icon
550
Voyager Therapeutics
VYGR
$189M
$172K ﹤0.01%
10,000
– –
20 21
22
23 24

Similar funds

SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
BC
Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return

Weiss Multi-Strategy Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, Weiss Multi-Strategy Advisers held 758 positions worth $4.93B, up 30% from $3.78B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Weiss Multi-Strategy Advisers deployed $1.17B of net new capital in Q3 2019, opening 275 new positions and adding to 122 existing holdings. Its largest new stake was Zayo Group Holdings, Inc.: 2,371,034 shares worth $80.4M.

By sector, the portfolio is most concentrated in Real Estate at 18% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was VICI Properties, an estimated $58.6M trimmed.

  • Weiss Multi-Strategy Advisers's largest Q3 2019 buy was Zayo Group Holdings, Inc.: 2,371,034 shares worth $80.4M.
  • Weiss Multi-Strategy Advisers added most to Celgene Corp in Q3 2019, an estimated $106M increase.
  • Weiss Multi-Strategy Advisers's biggest Q3 2019 reduction was VICI Properties, cutting an estimated $58.6M.
  • Weiss Multi-Strategy Advisers fully exited Cousins Properties in Q3 2019, selling an estimated $87.3M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 15% of its $4.93B portfolio in Q3 2019.
  • Weiss Multi-Strategy Advisers opened 275 new positions and closed 194 in Q3 2019.
  • Weiss Multi-Strategy Advisers's portfolio value rose 30% quarter-over-quarter to $4.93B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.